Other Research Gene therapy In partnership with the University of Liverpool, we have just begun a PhD programme looking at developing a gene therapy cure for AKU. We hope that the preliminary research conducted will create a foundation to explore the possibility of...
Hypertyrosinaemia We are currently conducting research into treating nitisinone-induced hypertyrosinaemia¹ in partnership with a number of collaborators including the University of Liverpool. Nitisinone is an extremely effective treatment which reduces homogentisic...
Information For International Patients aimAKU aimAKU is the patient support group for AKU patients and their families in Italy. Access their website here. AKU Society APAC The AKU Society of Asia-Pacific is the patient support group for AKU patients and their families...
Our Staff Staff Nick Sireau CEO & Chairman of the Trustees Ever since Nick’s sons were diagnosed with AKU, he has been involved with the society. When it was set up in 2003, Nick became a trustee and has served as CEO since 2010. Now, as Chairman of the trustees,...
DevelopAKUre The DevelopAKUre programme was a series of major international clinical trials, run by a consortium of 12 European partners. It aimed to study a drug, called nitisinone, and assess its effectiveness in treating AKU. The DevelopAKUre clinical trials...
